Pierre Morel

Active 1989–2025

71
Papers
21,639
Citations
51
h-index
68
i10-index

Citations

Citations per year for Pierre Morel1920: 1 citations1989: 2 citations1992: 1 citations1993: 9 citations1994: 10 citations1995: 12 citations1996: 22 citations1997: 46 citations1998: 51 citations1999: 52 citations2000: 69 citations2001: 99 citations2002: 100 citations2003: 151 citations2004: 131 citations2005: 166 citations2006: 156 citations2007: 189 citations2008: 227 citations2009: 156 citations2010: 204 citations2011: 188 citations2012: 146 citations2013: 155 citations2014: 152 citations2015: 130 citations2016: 95 citations2017: 97 citations2018: 112 citations2019: 333 citations2020: 349 citations2021: 323 citations2022: 240 citations2023: 149 citations2024: 266 citations2025: 100 citations2026: 5 citations1921–1988: no citations, so these years are not shown1990–1991: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,877 citing papers, 25% of this breakdownFrance: 653 citing papers, 8.7% of this breakdownGermany: 636 citing papers, 8.5% of this breakdownItaly: 550 citing papers, 7.3% of this breakdownUnited Kingdom: 486 citing papers, 6.5% of this breakdownChina: 304 citing papers, 4.1% of this breakdownSpain: 303 citing papers, 4% of this breakdownCanada: 283 citing papers, 3.8% of this breakdownNetherlands: 216 citing papers, 2.9% of this breakdownJapan: 206 citing papers, 2.7% of this breakdownSwitzerland: 197 citing papers, 2.6% of this breakdownAustralia: 168 citing papers, 2.2% of this breakdown
0%25%Other 21.7%

Fields

  • Medicine78.8%
  • Biochemistry, Genetics and Molecular Biology9.1%
  • Computer Science5.3%
  • Immunology and Microbiology1.9%
  • Neuroscience1.9%
  • Pharmacology, Toxicology and Pharmaceutics1.2%
  • Other1.8%

Topics

  • Lymphoma Diagnosis and Treatment12.8%
  • Acute Myeloid Leukemia Research8.4%
  • Chronic Lymphocytic Leukemia Research5.9%
  • CNS Lymphoma Diagnosis and Treatment4.2%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment3.3%
  • CAR-T cell therapy research3.1%
  • Other62.3%

Coauthors

All papers

Open in search
  1. CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

    Authors: , , , , , , , , , , , , - New England Journal of Medicine 2002 cited by 5,562

  2. International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes

    Authors: , , , , , , , , , , , , , , - Blood 1997 cited by 4,457

  3. The medicinal chemistry of carboranes

    Authors: , , , , , , - Coordination Chemistry Reviews 2002 cited by 656

  4. Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients Age 60 Years and Younger: Long-Term Results of the Randomized Phase II PRECIS Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Khê Hoang‐Xuan, Carole Soussain, on behalf of the LOC Network for CNS Lymphoma - Journal of Clinical Oncology 2022 cited by 101

  5. Gramm: grammar of graphics plotting in Matlab

    Authors: - The Journal of Open Source Software, J. Open Source Softw. 2018 cited by 230

  6. Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results of the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lucette Lacomblez, N. Martin–Duverneuil, Daniel Delgadillo, Isabelle Turbiez, L. Feuvret, Nathalie Cassoux, Valérie Touitou, Damien Ricard, Khê Hoang‐Xuan, Carole Soussain, on behalf of the Intergroupe GOELAMS–ANOCEF and the LOC Network for CNS Lymphoma - Journal of Clinical Oncology 2019 cited by 276

  7. What makes a reach movement effortful? Physical effort discounting supports common minimization principles in decision making and motor control

    Authors: , , - PLoS Biology 2017 cited by 143

  8. Severe adult hemophagocytic lymphohistiocytosis (HLHa) correlates with HLH-related gene variants

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Morgane Cheminant, Felipe Suárez, Olivier Hermine, Fabrice Bonnet, Pascal Godemer, Gandhi Damaj, Olivier Fain, Olivier Lambotte, David Launay, Louis Terriou, C. Larroche, Estibaliz Lazaro, Jean‐François Viallard, Francois Liffermann, Olivier Lortholary, Marc Michel, Jean‐Marie Michot, Pierre Morel, Frédéric Pène, Antoinette Perlat, G. Urbanski - Journal of Allergy and Clinical Immunology 2023 cited by 27

  9. Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , R. Siebert, David Vallois, Philippe Gaulard, Olivier Tournilhac, Laurence de Leval - Haematologica 2022 cited by 72

  10. Report of consensus Panel 4 from the 11th International Workshop on Waldenstrom's macroglobulinemia on diagnostic and response criteria

    Authors: , , , , , , , , , , , , , , , - Seminars in Hematology 2023 cited by 64

  11. JAK2 allele burden is correlated with a risk of venous but not arterial thrombosis

    Authors: , , , , , , - Thrombosis Research 2022 cited by 27

  12. International prognostic scoring system for Waldenström macroglobulinemia

    Authors: , , , , , , , , , , , , , - Blood 2009 cited by 413

  13. Response assessment in Waldenström macroglobulinaemia: update from the VIth International Workshop

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - British Journal of Haematology 2012 cited by 276

  14. Fabrication of Polymer Microneedles Using a Two-Photon Polymerization and Micromolding Process

    Authors: , , , , , , , , - Journal of Diabetes Science and Technology 2009 cited by 119

  15. Diagnostics in Waldenström’s macroglobulinemia: a consensus statement of the European Consortium for Waldenström’s Macroglobulinemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Leukemia 2022 cited by 45

  16. Bortezomib-Dexamethasone, Rituximab, and Cyclophosphamide as First-Line Treatment for Waldenström's Macroglobulinemia: A Prospectively Randomized Trial of the European Consortium for Waldenström's Macroglobulinemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 cited by 41

  17. Ascorbic acid (vitamin C) synergistically enhances the therapeutic effect of targeted therapy in chronic lymphocytic leukemia

    Authors: , , , , , , , , , - Journal of Experimental & Clinical Cancer Research 2020 cited by 34

  18. Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia

    Authors: , , , , , , , , , , , - Seminars in Oncology 2003 cited by 333

  19. Statistical determinants of visuomotor adaptation along different dimensions during naturalistic 3D reaches

    Authors: , , , - Scientific Reports 2022 cited by 16

  20. Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM

    Authors: , , , , , , , , , , , , , - Leukemia Research 2010 cited by 195

  21. Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2014 cited by 166

  22. Efficacy of bortezomib, cyclophosphamide and dexamethasone in treatment-naive patients with high-risk cardiac AL amyloidosis (Mayo Clinic stage III)

    Authors: , , , , , , , , , , , , , , , , - Haematologica 2014 cited by 129

  23. A revised international prognostic score system for Waldenström’s macroglobulinemia

    Authors: , , , , , , , , , , , , , , , , , , , , , - Leukemia 2019 cited by 109

  24. A Recurrent Activating Missense Mutation in Waldenström Macroglobulinemia Affects the DNA Binding of the ETS Transcription Factor SPI1 and Enhances Proliferation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas Mercher, Saïd Aoufouchi, Nathalie Droin, Christel Guillouf, Florence Nguyen‐Khac, Olivier Bernard - Cancer Discovery 2019 cited by 33